课题基金 / 基金详情

Combination of IAP antagonism and immune checkpoint blockade to treat brain cancer

Combination of IAP antagonism and immune checkpoint blockade to treat brain cancer
IAP拮抗和免疫检查点阻断相结合治疗脑癌
批准号：
341720
负责人：
Korneluk Robert G
金额：
$7.29万
依托单位：
Children's Hospital of Eastern Ontario- Ottawa Children's Treatment Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-01-01 至 2017-01-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=341720&lang=en
关键词：
Apoptosis Cancer Immunotherapy Combination Synergy Cytotoxic T-Lymphocyte Glioblastoma Iap Antagonists Immune Checkpoint Inhibitors Smac Mimetics Tnfalpha Tumor Immunity

项目摘要

项目成果

Korneluk Robert G的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A promising class of drugs have emerged on the market in recent years that make use of the patient's own immune system to fight cancer, fulfilling a long-held belief that 'immunotherapy' can help in the treatment of cancer. The drugs called "immune checkp
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of the Inhibitors of Apoptosis (IAPs) in health and disease
Combined IAP antagonism and immunotherapy for cancer treatment
Combined IAP antagonism and immunotherapy for cancer treatment
Role of cellular Inhibitors of Apoptosis (cIAPs) in muscle biology and disease
海外基金